These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34583866)

  • 1. Effectiveness of Dynamic Contrast Enhanced MRI with a Split Dose of Gadoterate Meglumine for Detection of Prostate Cancer.
    Fan X; Chatterjee A; Pittman JM; Yousuf A; Antic T; Karczmar GS; Oto A
    Acad Radiol; 2022 Jun; 29(6):796-803. PubMed ID: 34583866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer.
    Chatterjee A; He D; Fan X; Wang S; Szasz T; Yousuf A; Pineda F; Antic T; Mathew M; Karczmar GS; Oto A
    Acad Radiol; 2018 Mar; 25(3):349-358. PubMed ID: 29167070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal intensity form of the Tofts model for quantitative analysis of prostate dynamic contrast enhanced MRI data.
    Fan X; Chatterjee A; Medved M; Oto A; Karczmar GS
    Phys Med Biol; 2021 Jan; 66(2):025002. PubMed ID: 33181487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial input function for quantitative dynamic contrast-enhanced MRI to diagnose prostate cancer.
    Ziayee F; Mueller-Lutz A; Gross J; Ullrich T; Quentin M; Arsov C; Antoch G; Wittsack HJ; Schimmöller L
    Diagn Interv Radiol; 2022 Mar; 28(2):108-114. PubMed ID: 35548894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
    Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
    Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
    Ziayee F; Müller-Lutz A; Gross J; Quentin M; Ullrich T; Heusch P; Arsov C; Rabenalt R; Albers P; Antoch G; Wittsack HJ; Schimmöller L
    Magn Reson Imaging; 2018 Nov; 53():28-33. PubMed ID: 29902565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer.
    Klawer EME; van Houdt PJ; Pos FJ; Heijmink SWTPJ; van Osch MJP; van der Heide UA
    NMR Biomed; 2018 Sep; 31(9):e3946. PubMed ID: 29974981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A compact solution for estimation of physiological parameters from ultrafast prostate dynamic contrast enhanced MRI.
    He D; Fan X; Chatterjee A; Wang S; Medved M; Pineda FD; Yousuf A; Antic T; Oto A; Karczmar GS
    Phys Med Biol; 2019 Aug; 64(15):155012. PubMed ID: 31220816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard tofts model in the diagnosis of prostate cancer.
    Zhou X; Fan X; Chatterjee A; Yousuf A; Antic T; Oto A; Karczmar GS
    Phys Eng Sci Med; 2023 Sep; 46(3):1215-1226. PubMed ID: 37432557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.
    Lee CH; Vellayappan B; Taupitz M; Hamm B; Asbach P
    Eur Radiol; 2019 Dec; 29(12):6982-6990. PubMed ID: 31264013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
    Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
    Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.
    Vos EK; Litjens GJ; Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ; Scheenen TW
    Eur Urol; 2013 Sep; 64(3):448-55. PubMed ID: 23751135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
    Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
    Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer.
    Azahaf M; Haberlay M; Betrouni N; Ernst O; Behal H; Duhamel A; Ouzzane A; Puech P
    J Magn Reson Imaging; 2016 Mar; 43(3):737-49. PubMed ID: 26303794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial input functions (AIFs) measured directly from arteries with low and standard doses of contrast agent, and AIFs derived from reference tissues.
    Wang S; Fan X; Medved M; Pineda FD; Yousuf A; Oto A; Karczmar GS
    Magn Reson Imaging; 2016 Feb; 34(2):197-203. PubMed ID: 26523650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic analysis of prostate cancer using independent component analysis.
    Mehrabian H; Da Rosa M; Haider MA; Martel AL
    Magn Reson Imaging; 2015 Dec; 33(10):1236-1245. PubMed ID: 26297961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
    He D; Chatterjee A; Fan X; Wang S; Eggener S; Yousuf A; Antic T; Oto A; Karczmar GS
    Invest Radiol; 2018 Oct; 53(10):609-615. PubMed ID: 29702525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
    Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
    Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.